BBlogFlow

Contributor: There's federal progress on women's health. No joke - Los Angeles Times

·Oct 3, 2026
Source: Los Angeles Times
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : Tubes of Testim testosterone gel

By Jennifer Weiss-WolfGuest contributor  Oct. 3, 2026 3:03 AM PT Menopause has been having a moment lately, and Washington is taking notice. On Sept. 16, the Senate held its first hearing on the dismal state of federally funded menopause research and vast gaps in treatment and care. Within 24 hours, the Department of Health and Human Services also convened pharmaceutical manufacturers and physicians to troubleshoot the alarming lack of availability of estradiol patches, an essential menopause hormone treatment, and the Food and Drug Administration held a full day of expert panels on female-dosed testosterone, which is currently only FDA-approved for men. One week later, Health and Human Services joined the American Urological Assn. for a discussion about a silent killer of postmenopausal women: urosepsis from recurrent urinary tract infections. There is a simple solution — localized vaginal estrogen — and yet because of outdated guidelines and lack of clinician training, the medication is too often ignored or denied. Nor is the prescription routinely covered by Medicare, despite its well-established health and longevity benefits for women over age 65.

This article is an excerpt. To read the full content, visit the original source. Los Angeles Times

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Former press secretary Karoline Leavitt lands her next gig: Fox News contributor - CTV News

AtlanticNova ScotiaNew BrunswickPrince Edward Island Newfoundland and LabradorCalgaryLethbridgeKitchenerGuelphNorthern OntarioSudburyNorth BaySault Ste. MarieTimminsOttawaKingstonBrockvillePembrokeReginaYorktonSaskatoonPrince AlbertTorontoWatchWeatherPeelHamiltonDurhamYorkHaltonNiagaraQueen's ParkToronto City HallIn PicturesVancouverVancouver IslandCanadaLocal SpotlightRoyal FamilyPoliticsNanosPower PlayQuestion PeriodFederal Election 2025WorldMideast ConflictRussia-Ukraine WarWatchLatestCaptured on CameraPoliticsLifestyleConsumerHealthExplainedEntertainmentTechnologyDeception DecodedAutosEnvironmentBusinessInflationReal EstateAutos

CTV News·

Contributor: Democrats can become the party of business - Los Angeles Times

Voices Kurt Bardella Cargo containers are stacked on a cargo ship moving through the Panama Canal. Exporters in the U. S. can suffer disproportionately when overseas markets seek to punish the Trump administration. (Matias Delacroix / Associated Press) By Kurt BardellaGuest contributor  Oct. 4, 2026 3:01 AM PT Click here to listen to this article See more from the L. A. Times in Google Search. Set us as preferred For half a century, Republicans have worn the “party of business” label like a permanent badge — tax cuts, deregulation, tough trade talk — while Democrats have too often ceded the ground, treating economic strength as someone else’s brand to react to rather than a story to tell. A new survey commissioned by the nonpartisan U. S.-Asia Fair Market Alliance hands Democrats a rare gift: hard data showing there is a genuine, winnable opening on economic fairness, and it maps precisely onto the values Democrats already claim. The numbers are hard to argue with. A poll of 1,000 nationally representative voters and 318 D.

Los Angeles Times·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·